References
- Fetterman BL, Saunders JE, Luxford WM. Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol 1996;17:529–36.
- Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109:1–17.
- Chinese Journal of Otorhinolaryngology Head and Neck Surgery Editorial Board, Chinese Medical Association Archives of Otolaryngology Head and Neck Surgery Branch. Sudden sensorineural hearing loss diagnosis and treatment guidelines, 2005, Ji Nan. China J Otorhinolaryngol Head Neck Surg 2006;41:325.
- Kanzaki J, Inoue Y, Ogawa K, Fukuda S, Fukushima K, Gyo K, Effect of single-drug treatment on idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 2003;30:123–7.
- Liu F, Huang W, Wang Z, Chen Q, Liu X, Li S, Noninvasive evaluation of endolymphatic space in healthy volunteers using magnetic resonance imaging. Acta Otolaryngol 2011;131:247–57.
- Plontke SK, Siedow N, Wegener R, Zenner HP, Salt AN. Cochlear pharmacokinetics with local inner ear drug delivery using a three-dimensional finite-element computer model. Audiol Neurootol 2007;12:37–48.
- Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 2001;22:18–23.
- Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF. Intratympanic dexmethasone for sudden sensorineural hearing loss after failure of system therapy. Laryngoscope 2006;117:3–15.
- Kakehata S, Sasaki A. Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes. Otol Neurotol 2006;27:604–8.
- Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2006;29:453–60.
- Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A, Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 2006;134:940–5.
- Plaza G, Herraiz C. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surg 2007;137:74–8.
- Wijck FV, Staecker H, Lefebver PP. Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment. Acta Otolaryngol 2007;127:1012–17.
- Wilkins SA, Mattox DE, Lyles A. Evaluation of a “shotgun” regimen for sudden hearing loss. Otolaryngol Head Neck Surg 1987;97:474–80.
- Banerjee A, Parnes LS. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol 2005;26:878–81.
- Plaza G, Herraiz C. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surg 2007;137:74–8.
- Battista RA. Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2005;132:902–5.
- Herr BD, Marzo SJ. Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2005;132:527–31.
- Kiliç R, Safak MA, Oğuz H, Kargin S, Demirci M, Samim E, Intratympanic methylprednisolone for sudden sensorineural hearing loss. Otol Neurotol 2007;28:312–16.
- Sudo M, Sando I, Ikui A, Suzuki C. Narrowest (isthmus) portion of eustachian tube: a computer-aided three-dimensional reconstruction and measurement. Ann Otol Rhinol Laryngol 1997;106:583–8.